These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22085282)

  • 1. Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression.
    Kuil J; Buckle T; Oldenburg J; Yuan H; Borowsky AD; Josephson L; van Leeuwen FW
    Mol Pharm; 2011 Dec; 8(6):2444-53. PubMed ID: 22085282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-functionalized luminescent iridium complexes for lifetime imaging of CXCR4 expression.
    Kuil J; Steunenberg P; Chin PT; Oldenburg J; Jalink K; Velders AH; van Leeuwen FW
    Chembiochem; 2011 Aug; 12(12):1897-903. PubMed ID: 21739561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS.
    Buckle T; Kuil J; van den Berg NS; Bunschoten A; Lamb HJ; Yuan H; Josephson L; Jonkers J; Borowsky AD; van Leeuwen FW
    PLoS One; 2013; 8(1):e48324. PubMed ID: 23326303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide.
    Kuil J; Buckle T; Yuan H; van den Berg NS; Oishi S; Fujii N; Josephson L; van Leeuwen FW
    Bioconjug Chem; 2011 May; 22(5):859-64. PubMed ID: 21480671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma.
    Sand LGL; Buckle T; van Leeuwen FWB; Corver WE; Kruisselbrink AB; Jochemsen AG; Hogendoorn PCW; Szuhai K
    BMC Cancer; 2017 May; 17(1):383. PubMed ID: 28549419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and application of fluorescein- and biotin-labeled molecular probes for the chemokine receptor CXCR4.
    Oishi S; Masuda R; Evans B; Ueda S; Goto Y; Ohno H; Hirasawa A; Tsujimoto G; Wang Z; Peiper SC; Naito T; Kodama E; Matsuoka M; Fujii N
    Chembiochem; 2008 May; 9(7):1154-8. PubMed ID: 18412193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid Imaging Labels: Providing the Link Between Mass Spectrometry-Based Molecular Pathology and Theranostics.
    Buckle T; van der Wal S; van Malderen SJ; Müller L; Kuil J; van Unen V; Peters RJ; van Bemmel ME; McDonnell LA; Velders AH; Koning F; Vanhaeke F; van Leeuwen FW
    Theranostics; 2017; 7(3):624-633. PubMed ID: 28255355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution imaging and single-cell analysis via laser ablation-inductively coupled plasma-mass spectrometry for the determination of membranous receptor expression levels in breast cancer cell lines using receptor-specific hybrid tracers.
    Van Acker T; Buckle T; Van Malderen SJM; van Willigen DM; van Unen V; van Leeuwen FWB; Vanhaecke F
    Anal Chim Acta; 2019 Oct; 1074():43-53. PubMed ID: 31159938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.
    Ziarek JJ; Getschman AE; Butler SJ; Taleski D; Stephens B; Kufareva I; Handel TM; Payne RJ; Volkman BF
    ACS Chem Biol; 2013 Sep; 8(9):1955-63. PubMed ID: 23802178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions.
    Wang J; He L; Combs CA; Roderiquez G; Norcross MA
    Mol Cancer Ther; 2006 Oct; 5(10):2474-83. PubMed ID: 17041091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry.
    Choi WT; Kumar S; Madani N; Han X; Tian S; Dong CZ; Liu D; Duggineni S; Yuan J; Sodroski JG; Huang Z; An J
    Biochemistry; 2012 Sep; 51(36):7078-86. PubMed ID: 22897429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors.
    Hanaoka H; Mukai T; Tamamura H; Mori T; Ishino S; Ogawa K; Iida Y; Doi R; Fujii N; Saji H
    Nucl Med Biol; 2006 May; 33(4):489-94. PubMed ID: 16720240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of labeling by near infrared dyes of the polyproline linker for bivalent-type CXCR4 ligands.
    Nomura W; Aikawa H; Taketomi S; Tanabe M; Mizuguchi T; Tamamura H
    Bioorg Med Chem; 2015 Nov; 23(21):6967-73. PubMed ID: 26453409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists.
    Işbilir A; Möller J; Arimont M; Bobkov V; Perpiñá-Viciano C; Hoffmann C; Inoue A; Heukers R; de Graaf C; Smit MJ; Annibale P; Lohse MJ
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29144-29154. PubMed ID: 33148803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorophore labeling enables imaging and evaluation of specific CXCR4-ligand interaction at the cell membrane for fluorescence-based screening.
    Nomura W; Tanabe Y; Tsutsumi H; Tanaka T; Ohba K; Yamamoto N; Tamamura H
    Bioconjug Chem; 2008 Sep; 19(9):1917-20. PubMed ID: 18707146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.
    Cheng Z; Wu Y; Xiong Z; Gambhir SS; Chen X
    Bioconjug Chem; 2005; 16(6):1433-41. PubMed ID: 16287239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and Biological Characterizations of Novel High-Affinity Fluorescent Probes with Overlapped and Distinctive Binding Regions on CXCR4.
    Zhu S; Meng Q; Schooley RT; An J; Xu Y; Huang Z
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31412600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agents.
    Lesniak WG; Sikorska E; Shallal H; Behnam Azad B; Lisok A; Pullambhatla M; Pomper MG; Nimmagadda S
    Mol Pharm; 2015 Mar; 12(3):941-53. PubMed ID: 25590535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC.
    van den Berg NS; Buckle T; Kuil J; Wesseling J; van Leeuwen FW
    Transl Oncol; 2011 Aug; 4(4):234-40. PubMed ID: 21804919
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.